Pulmonary Arterial Hypertension Treatment Market


Pulmonary Arterial


Treatment Market

Share, Global Trends,

Analysis, Research, Report,


Segmentation and Forecast,


Future Market Insights



Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting

services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,

technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.

We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.

Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and


We have a global presence with delivery centers across India specializing in providing global research reports and country

research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.

We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for

our client.

Research Capabilities

• Customized Research

• Syndicated Research

• Investment Research

• Social Media Research

Sector Coverage

• Automotive and Transportation

• Electronics, Semiconductor, and ICT

• Retail and Consumer Products

• Industrial Automation and Equipment

• Chemicals & Materials

• Food and Beverages

• Services and Utilities

• Energy, Mining, Oil, and Gas







Social Media


Subscription Information

For detailed subscription information please contact

Hari. T (Sr. Manager - Global Business Development)

T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268

Email: hari.t@futuremarketinsights.com

Report Description

According to World Health Organization (WHO), raised blood pressure is estimated to

cause 7.5 million deaths around the world. Hypertension is a risk factor for coronary

heart disease, ischemic and hemorrhagic stroke. In addition complications of

hypertension includes peripheral vascular disease, heart failure, renal impairment, retinal

hemorrhage and visual impairment.

Having family history of Pulmonary Arterial Hypertension, change in life style, unhealthy

food, and physical inactivity causes hypertension.

To treat pulmonary atrial hypertension following treatments are available



Medications include blood vessel dilators (vasodilators), Endothelin receptor antagonists,

phosphodiesterase III inhibitors, calcium channel blockers, anticoagulants, diuretics.

Browse Full Report@ http://www.futuremarketinsights.com/reports/pulmonary-arterialhypertension-treatment-market

Atrial septostomy and Transplantation are the two surgery option for patients who

suffering from severe pulmonary atrial hypertension. Transplantation is may be an option

for younger people who are suffering from idiopathic pulmonary hypertension.

Report Description

Pulmonary Arterial Hypertension Treatment Market: Drivers and Restraints

According to World Health Organization, Globally the prevalence rate of hypertension

was 40% in adults who aged 25 and above in the year 2008. The prevalence rate is high in

Africa region and Americas having less prevalence rate in hypertension. Change in the life

style, family history of pulmonary atrial hypertension, unhealthy food, and physical

inactivity are the risk factors for hypertension as well as drivers for this market. Raising

the geriatric population around the world also driver for pulmonary atrial hypertension

treatment market. Guidelines form government organizations such as World Health

Organization (WHO), Center for Disease Control and Prevention plays a major role in the

prevention of pulmonary atrial hypertension treatment.

Pulmonary Arterial Hypertension Treatment Market: Segmentation

Pulmonary Arterial Hypertension Treatment Market is segmented into following types:

Based on Treatment


Based on End User


Drug store

Hospital Pharmacies

Report Description

Request Free Report Sample@


Pulmonary Arterial Hypertension Treatment Market: Overview

With good awareness about healthcare among people and guidance from international

organizations about the Pulmonary Arterial Hypertension Treatment, the market is

expected to have a healthy growth in the forecast period (2016-2026)

Pulmonary Arterial Hypertension Treatment Market: Region- wise Outlook

Depending on geographic regions, the global Pulmonary Arterial Hypertension Treatment

market is segmented into seven key regions: North America, South America, Eastern

Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa.

Pulmonary Arterial Hypertension Treatment is high in North America because it is highly

developed region, having good healthcare setup and people are having good awareness

about health care. Asia Pacific is expected to grow at a remarkable CAGR. Europe also

having good growth in this market.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1218

Pulmonary Arterial Hypertension Treatment Market: Key Players

Some of the key players in this market are

Report Description

Pfizer inc.

Bristol myers co

Novartis AG.

GlaxoSmithKline Pharmaceuticals Limited


Dr. Reddy’s Laboratories Ltd.

Thank You!

To know more about us, please visit our website:


For sales queries or new topics email us on:


For other queries contact: Mr. Sudip Saha

Future Market Insights: 616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989, United States

T: +1-347-918-3531 | D: +1-845-579-5705

More magazines by this user
Similar magazines